Post on AMGN Morphs Into Screed About Smart & Dumb Monkeys

I don’t own it, but the NFTRH+ segment in NFTRH 464 noted… “Meanwhile, old friend AMGN is looking interesting these days; somewhat similar to how ABBV looked early this year. If 180 is taken out the target is 210.” …using this chart… Boink… Here is the ABBV chart that it was comp’d to… I am going to stick to my guns for now with a … Continue reading Post on AMGN Morphs Into Screed About Smart & Dumb Monkeys

ABBV Replacing GILD

You could say GILD replaced ABBV after I took its profit and now ABBV is back after I took GILD’s profit. It may sound slick, but it is really just late stage bull market trading; reaping here, planting there and managing risk and limiting losses everywhere. ABBV pulled back, almost as if on command after it hit our 1st target of 75. The SMA 50 … Continue reading ABBV Replacing GILD

nftrh plus

NFTRH+ Trade Idea ABBV, and a Note on Other Market Items (public post)

Unlike Semi and Tech, certain items that have been relatively weak are now strengthening. Financials, Materials and Healthcare (ex-medical devices, which had been booming). It seems obvious that the big momos (i.e. hedge funds, quant boxes and the day traders swimming in their wake) have decided it’s time to abandon the high fliers and favor relative value. As for ABBV, it was highlighted in April … Continue reading NFTRH+ Trade Idea ABBV, and a Note on Other Market Items (public post)

nftrh plus

NFTRH+; Is This Bio Stock the Star Semi Stock of a Year Ago?

[edit] per the weekly report’s NFTRH+ Notes segment, we have introduced an initial target of 75 and extended the best target to a less conservative 88 from 84. Here is the weekly chart as tracked in NFTRH reports… The title of the post is a cute way of comparing what we saw in prime Semiconductor Equipment company Lam Research (LRCX) last June to the chart … Continue reading NFTRH+; Is This Bio Stock the Star Semi Stock of a Year Ago?